HaynesR. Introduction. In: HaynesRTaylorDSackettD, eds. Compliance In Health Care. Baltimore: Johns Hopkins University Press, 1979.
2.
TrostleJ. Medical compliance as an ideology. Soc Sci Med1988;27(12): 1299–308.
3.
HopewellPC. The cure: organisation and administration of therapy for tuberculosis. In: PorterJDHMcAdamKPWJ, eds. Tuberculosis: Back to the Future. Chichester: John Wiley & Sons Ltd, 1993.
4.
Singapore Tuberculosis Service/British Medical Research Council. Assessment of a daily combined preparation of isoniazid, rifampicin and pyrazinamide in a controlled trial of three 6-month regimens for smear positive pulmonary tuberculosis. Am Rev Respir Dis1991;143:707–12.
5.
Hong Kong Chest Service/British Medical Research Council. Acceptability, compliance and adverse reactions when isoniazid, rifampicin and pyrazinamide are given as a combined formulation or separately during tree times weekly antituberculosis chemotherapy. Am Rev Respir Dis1989;140(6):1618–22.
6.
ElliotA. An approach to the management of tuberculosis in HIV endemic areas. Trop Doct1992;22(4): 147–50.
7.
NunnPBoulosRC. Workshop 3: Case finding and clinical management. In: PorterJDHMcAdamKPWJ, eds. Tuberculosis: Back to the Future. Chichester: John Wiley & Sons Ltd, 1993.
8.
MMWR. Approaches to improving adherence to antituberculosis therapy-South Carolina and New York, 1986–1991. MMWR Morb Mortal Wkly Rep1993;42(4):74–5, 81.
9.
WilkinsonD. High-compliance tuberculosis treatment programme in a rural community. Lancet1994;343:647–8.
